CAS 2682114-54-9

SP-96

CAS : 2682114-54-9

Formule : C₂₅H₂₀FN₇O

Degré de pureté : 99%

Masse moléculaire : 453.471

Ref: IN-DA020A82

SP-146

CAS : 2682114-54-9

SP-146

Degré de pureté : ≥95%

Masse moléculaire : 453.47g/mol

Ref: 54-BUP07528

SP-96

CAS : 2682114-54-9

SP-96

Degré de pureté : ≥98%

Masse moléculaire : 453.47g/mol

Ref: 54-BUP05012

SP-96

CAS : 2682114-54-9

SP-96: Aurora B inhibitor, IC50=0.316 nM, selectively hinders MDA-MD-468 growth, GI50=107 nM, for triple-negative breast cancer research.

Formule : C₂₅H₂₀FN₇O

Degré de pureté : 99.54%

Couleur et forme : Solid

Masse moléculaire : 453.47

Ref: TM-T41256

1-(3-Fluorophenyl)-3-(3-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)urea

CAS : 2682114-54-9

Formule : C₂₅H₂₀FN₇O

Degré de pureté : 99%

Masse moléculaire : 453.481

Ref: 10-F549543

SP-96

CAS : 2682114-54-9

SP-96 is an anticancer drug that acts as a potent inhibitor of kinases, which are enzymes that play a key role in the regulation of cell growth and division. It has been shown to induce apoptosis, or programmed cell death, in cancer cells by blocking the activity of specific kinases. SP-96 is an analog of tolvaptan, a drug used to treat fluid retention in patients with certain medical conditions. This drug has been tested on Chinese hamster ovary (CHO) and human cancer cell lines, where it showed significant inhibition of protein kinase activity. SP-96 has also shown promise as a potential treatment for tumors due to its ability to inhibit tumor growth and promote apoptosis in cancer cells. The drug is excreted primarily through urine, making it easy for the body to eliminate.

Formule : C₂₅H₂₀FN₇O

Degré de pureté : Min. 95%

Masse moléculaire : 453.5 g/mol

Ref: 3D-HHE11454